Fig. 7From: Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson’s disease models in vitro and vivoThe morphology of dopaminergic neurons, number of viable dopaminergic neurons, TH protein level, and the formation of Lewy bodies in substantia nigra of rotenone-induced PD mouse model transduced with NDI1. A The morphology of dopaminergic neurons in the right SNpc was examined using H&E staining. Dopaminergic neurons were indicated with circles. (Scale bar: 50 μm). B The presence of viable dopaminergic neurons in the SNpc (indicated with circles) and VTA (out of circles) was examined using TH immunohistochemistry. Brain sections were stained with TH antibody. TH-positive cells were counted to evaluate viable dopaminergic neurons. Scale bar = 500 μm. C–F Statistical analysis of the number of TH-positive dopaminergic neurons in the left and right VTA, and in the left and the right SNpc. G TH protein in the SN was examined by western blot using TH antibody with GAPDH as loading control. H, I Quantitative analysis of the TH level in the left and right SN. J The formation of Lewy bodies in dopaminergic neurons of right SNpc was examined by pS129 α-synuclein immunohistochemistry. The arrow showed Lewy body (brown). Rotenone + vector group compared with CMC + vector group, or CMC + NDI1 group compared with CMC + vector group, or Rotenone + NDI1 group compared with Rotenone + vector group, or Rotenone + NDI1 group compared with CMC + vector group, ns not significant, *P < 0.05, ***P < 0.001. SNpc substantia nigra pars compacta, VTA ventral tegmental area, TH tyrosine hydroxylaseBack to article page